ArticleBMC cancer2026

Safety, pharmacokinetics, pharmacodynamics and antitumor activity of legubicin in patients with advanced solid tumors, including lung cancer: a phase 1 dose-escalation and expansion trial.

Fengjuan Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.